News Releases
Nov 05, 2020
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Additional Formats
Nov 04, 2020
Sangamo Therapeutics Reports Business Highlights and Third Quarter 2020 Financial Results
Additional Formats
Oct 28, 2020
Sangamo Therapeutics Announces Third Quarter 2020 Conference Call and Webcast
Additional Formats
Oct 07, 2020
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment
Additional Formats
Sep 28, 2020
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Additional Formats
Sep 11, 2020
Sangamo Therapeutics Appoints Kenneth Hillan to Its Board of Directors
Additional Formats
Sep 02, 2020
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Additional Formats
Aug 10, 2020
Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference
Additional Formats
Aug 05, 2020
Sangamo Therapeutics Reports Business Highlights and Second Quarter 2020 Financial Results
Additional Formats
Jul 30, 2020
Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders
Additional Formats
Displaying 1 - 10 of 28